Curie.Bio (II)
Share
N°01 / About
About Curie.Bio (II)
Biotech VC helping founders launch therapeutics companies, from concept stage to the clinic, across any modality, therapeutic area or geography. Seed Fund writes $5-15M cheques through preclinical milestones; Breakout Fund backs clinical development with $35-70M. Over $1B raised.
N°02 / Thesis
Investment Focus
Location / RegionUnited States
Funding StageSeed
Industry Focus
Biotech
Therapeutics
Investor Signals Profile
active
Sweet Spot
Founders launching therapeutics companies, including founder ideas, existing biotechs and focused spinouts from biotechs, CROs or pharma.
28 signals on Curie.Bio (II)
12 bullish · 1 contrarian · 8 pitch do's · 3 don'ts · 4 GP profiles, each with its source. From €9/month, cancel anytime.
Michael's Network
People
Key People
Zach Weinberg, Alexis Borisy
Mert AktarPartner
Alexis BorisyCo-Founder & Operating Chairman
Christoph LengauerCo-Founder & Chief Science Strategy Officer (CSO)
Patrick LupardusVP, Drugmaker – Biologics (listed as Partner in the known-people list)